Pegvaliase was approved by FDA in 2018 for: (A) Phenylketonuria, (B) Pancreatic tumours, (C) Crohn's disease, (D) Glycogen storage disorders
Answer is A. Pegvaliase is a drug approved for the treatment of phenylketonuria. Chemically, it is a pegylated derivative of the enzyme phenylalanine ammonia-lyase that metabolizes phenylalanine to reduce its blood levels.